Accuray Announces CEO Change

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Accuray (Nasdaq: ARAY  ) today announced the resignation of Euan S. Thomson as president and chief executive officer and as a director of the board. The company's board of directors appointed Joshua H. Levine as his successor, effective immediately.

Prior to his appointment as CEO of Accuray, Levine served as CEO of Mentor Corp., which he left in 2009 following its acquisition by Johnson & Johnson (NYSE: JNJ  ) . Levine subsequently joined Immucor as CEO, where he stayed until October 2011, when the company was bought by TPG Capital.

The board praised Levine, 54, as "an experienced, commercially oriented CEO with diverse global healthcare experience necessary to lead the company to the next level of success."

Thomson joined Accuray in 2002. He led the the company as it went public in 2007 and in its 2011 acquisition of TomoTherapy. In his public statement following the announcement, Thomson expressed appreciation for his 10 years with Accuray but said that "it's time for change, for both the Company and me."Thomson is expected to continue in a consulting role with the company.

Accuray's Chairman, Louis J. Lavigne Jr., thanked Thomson for his leadership and said in a statement that the company is "now ready for the next stage of growth."

Accuray shares declined 3% in intraday trading. The stock is up over 50% thus far in 2012.

Keith Speights has no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2055784, ~/Articles/ArticleHandler.aspx, 10/21/2016 6:26:08 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:00 PM
ARAY $5.35 Down -0.30 -5.31%
Accuray CAPS Rating: ***
JNJ $113.44 Down -1.43 -1.24%
Johnson and Johnso… CAPS Rating: ****